PK/PD Modeling of Magnesium in the Mother and Neonate
Completed
Conditions studied: Magnesium Sulfate Pharmacokinetics and Pharmacodynamics
In brief
Determine significant correlations between maternal serum magnesium levels, and maternal and neonatal outcomes.
Key facts
- Study ID
- NCT01709630
- Run by
- Stanford University
- People needed
- 151
- Starts
- 2012-09-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2014-11-20
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pregnant women ages 18-45 years
- Magnesium sulfate exposure for preeclampsia, tocolysis, or neuroprotection
- Neonates (male or female) born at 24-42 weeks gestation
Where it is running
- Lucille Packard Children's Hospital at Stanford University Medical Center — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.